![Muffy Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Muffy Carter
Keine laufenden Positionen mehr
Profil
Martha J.
Carter formerly worked at Regulatory Affairs Professionals Society, as Director in 1999, Genetics Institute LLC, as Principal, ImmuLogic Pharmaceutical Corp., as Principal, GelTex Pharmaceuticals, Inc., as Vice President-Regulatory Affairs from 1998 to 2002, Proteon Therapeutics, Inc., as Chief Regulatory Officer in 2011, Aegerion Pharmaceuticals, Inc., as Chief Regulatory Officer from 2011 to 2016, Fisons Plc, as Principal, Trine Pharmaceuticals, Inc., as Senior Vice President-Regulatory Affairs from 2002 to 2008, EMD Serono, Inc., as Principal, and Albireo Pharma, Inc., as Chief Regulatory Officer from 2016 to 2023.
Ms. Carter received her undergraduate degree from Northeastern University.
Ehemalige bekannte Positionen von Muffy Carter
| Unternehmen | Position | Ende |
|---|---|---|
| ALBIREO PHARMA, INC. | General Counsel | 01.12.2023 |
| AEGERION PHARMACEUTICALS, INC. | General Counsel | 20.07.2016 |
| PROTARA THERAPEUTICS, INC. | General Counsel | 01.02.2011 |
Trine Pharmaceuticals, Inc.
 Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | General Counsel | 19.09.2008 |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | General Counsel | 01.01.2002 |
Ausbildung von Muffy Carter
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Regulatory Affairs Professionals Society
 Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Commercial Services |
Fisons Plc
 Fisons Plc Pharmaceuticals: OtherHealth Technology Manufactures and supplies ethical and proprietary medicines, veterinary products, laboratory and educational scientific equipment, clinical diagnostic supplies and garden products | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Wählen Sie MarketScreener 
